BEAM-103

N/A

Report date: 2025/12/29 20:01:35

Base Information

Drug NameBEAM-103
Drug Alias NameBEAM-103
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Stem cell growth factor receptor
TargetsStem cell growth factor receptor
Therapy Area/Indicationsbeta-ThalassemiaAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBeam Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBeam Therapeutics Inc
Inactive CompaniesN/A
Active Indicationsbeta-ThalassemiaAnemia, Sickle Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A